Hypothalamic expression of PD-L1: does it mediate hypothalamitis?

Cell Mol Immunol. 2019 Jun;16(6):625-626. doi: 10.1038/s41423-019-0232-2. Epub 2019 Apr 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents, Immunological / adverse effects*
  • Antineoplastic Agents, Immunological / therapeutic use
  • Autoimmunity
  • B7-H1 Antigen / immunology
  • B7-H1 Antigen / metabolism*
  • Drug-Related Side Effects and Adverse Reactions / metabolism*
  • Humans
  • Hypothalamus / metabolism*
  • Immunotherapy / adverse effects*
  • Immunotherapy / methods
  • Inflammation / etiology
  • Inflammation / metabolism*
  • Neoplasms / immunology
  • Neoplasms / therapy*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • B7-H1 Antigen
  • atezolizumab